Safety of perioperative statin use in high-risk patients undergoing major vascular surgery

Olaf Schouten; Miklos D Kertai; Jeroen J Bax; Anai E S Durazzo; Elena Biagini; Eric Boersma; Virginie H van Waning; Thomas W Lameris; Marc R H M van Sambeek; Don Poldermans

doi:10.1016/j.amjcard.2004.10.046

Safety of perioperative statin use in high-risk patients undergoing major vascular surgery

Am J Cardiol. 2005 Mar 1;95(5):658-60. doi: 10.1016/j.amjcard.2004.10.046.

Authors

Olaf Schouten¹, Miklos D Kertai, Jeroen J Bax, Anai E S Durazzo, Elena Biagini, Eric Boersma, Virginie H van Waning, Thomas W Lameris, Marc R H M van Sambeek, Don Poldermans

Affiliation

¹ Department of Vascular Surgery, Erasmus MC, Rotterdam, The Netherlands.

PMID: 15721114
DOI: 10.1016/j.amjcard.2004.10.046

Abstract

No clinical data are available on the influence of perioperative statin use on postoperative myopathy in patients undergoing major noncardiac surgery except for some case reports. Therefore, the aim of this study was to clarify the potential risk of myopathy in statin users who underwent major noncardiac surgery.

MeSH terms

Adult
Aged
Aged, 80 and over
Chi-Square Distribution
Female
Humans
Hypolipidemic Agents / administration & dosage
Hypolipidemic Agents / adverse effects*
Linear Models
Male
Middle Aged
Postoperative Period
Vascular Surgical Procedures*

Substances

Hypolipidemic Agents